Acute kidney injury (AKI) Flashcards
Define AKI
An abrupt loss of kidney function resulting in the retention of urea and other nitrogenous waste products and the dysregulation of extracellular volume and electrolytes.
NOTE: this can occur in patients with previously normal kidneys or in patients with pre-existing renal disease
KDIGO Classification of AKI
Increase in serum creatinine > 26μmol/L within 48 hrs
Increase in serum creatinine to > 1.5 times baseline within the preceding 7 days
Urine volume < 0.5 ml/kg/hr for 6 hour
Explain the aetiology/risk factors of Pre-renal AKI
(90% of all AKI are pre-renal)
Hypovolaemia,
Heart failure
Cirrhosis
Nephrotic syndrome
Hypotension (e.g. shock, sepsis, anaphylaxis)
Renal hypoperfusion (e.g. NSAIDs, ACE inhibitors, ARBs, renal artery stenosis)
Explain the aetiology/risk factors of Intrinsic Renal AKI
Glomerular - glomerulonephritis, haemolytic uraemic syndrome
Tubular - acute tubular necrosis
Interstitial- acute interstitial nephritis (e.g. NSAIDs, autoimmune)
Vasculitides - (e.g. Wegener’s granulomatosis)
Eclampsia
Explain the aetiology/risk factors of Post-Renal AKI
Post-Renal (due to obstruction) Calculi Urethral stricture Prostatic hypertrophy or malignancy Bladder tumour
Summarise the epidemiology of AKI
15% of adults admitted to hospital will develop an AKI
Most common in the ELDERLY
Recognise the presenting symptoms of AKI
Depends on underlying CAUSE
Oliguria/anuria (NOTE: abrupt anuria suggests post-renal obstruction)
Nausea/vomiting
Dehydration
Confusion
Recognise the signs of AKI on physical examination
Hypertension
Distended bladder
Dehydration-postural hypotension
Fluid overload (in heart failure, cirrhosis, nephrotic syndrome) - raised JVP, pulmonary and peripheral oedema
Pallor, rash, bruising (vascular disease)
Identify appropriate investigations for AKI
Urinalysis
Blood-suggests nephritic cause
Leucocyte esterase and nitrites - UTI
Glucose, Protein, Urine osmolality
Bloods - FBC, Blood film, U&Es, Clotting, CRP
Immunology - Serum immunoglobulins and protein electrophoresis for multiple myeloma. Also check for Bence-Jones proteins in the urine
ANA - associated with SLE, Also check anti-dsDNA antibodies (high in active lupus). Complement levels -low in active lupus
Anti-GBM antibodies - Goodpasture’s syndrome
Antistreptolysin-O antibodies - high after Streptococcal infection
Virology- check for hepatitis and HIV
Ultrasound - Check for post-renal cause, Look for hydronephrosis
Other Imaging
CXR-pulmonary oedema
AXR-renal stone
Generate a management plan for AKI
Treat the cause
FOUR main components to management: Protect patient from hyperkalaemia (calcium gluconate) Optimise fluid balance Stop nephrotoxic drugs Consider for dialysis
Monitor serum creatinine, sodium, potassium, calcium, phosphate and glucose
Identify and treat infection
Urgent relief of urinary tract obstruction
Refer to nephrology if intrinsic renal disease is suspected
Renal Replacement Therapy (RRT) considered if:
Hyperkalaemia refractory to medical management
Pulmonary oedema refractory to medical management
Severe metabolic acidaemia
Uraemic complication
Identify possible complications of AKI
Pulmonary oedema Acidaemia Uraemia Hyperkalaemia Bleeding
Summarise the prognosis for patients with AKI
Inpatient mortality varies depending on cause and comorbidities
Indicators of poor prognosis: Age Multiple organ failure Oliguria Hypotension CKD
Patients who develop AKI are at increased risk of developing CKD